PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, RJ, Brazil.\', \'National Institute for Science and Technology on Innovation in Diseases of Neglected Populations (INCT/IDPN), Center for Technological Development in Health (CDTS), Fiocruz, Rio de Janeiro, RJ, Brazil.\', \'Laboratório de Pesquisas sobre o Timo, IOC, Fiocruz, Rio de Janeiro, RJ, Brazil.\', \'National Institute for Science and Technology on Neuroimmunomodulation (INCT/NIM), IOC, Fiocruz, Rio de Janeiro, RJ, Brazil.\', \'Universidade Iguaçu, Nova Iguaçu, RJ, Brazil.\', \'Instituto de Tecnologia de Fármacos (Farmanguinhos), Fiocruz, Rio de Janeiro, RJ, Brazil.\', \'Laboratório de Macromoléculas, Diretoria de Metrologia Aplicada às Ciências da Vida, Instituto Nacional de Metrologia, Qualidade e Tecnologia-INMETRO, Duque de Caxias, RJ 25250-020, Brazil.\', \'Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos), Fiocruz, Rio de Janeiro, RJ, Brazil.\', \'Center for Genome Technology and Biomolecular Engineering, Columbia University, New York, NY 10027, USA.\', \'Department of Chemistry, Columbia University, New York, NY 10027, USA.\', \'Department of Chemical Engineering, Columbia University, New York, NY 10027, USA.\', \'Laboratory of Structural Biology, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.\', \'Laboratory of RNA Molecular Biology, Rockefeller University, New York, NY 10065, USA.\', \'Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool L7 3NY, UK.\', \'Instituto D\'Or de Pesquisa e Ensino, Rio de Janeiro, RJ, Brazil.\', \'Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil.\', \'Instituto Nacional de Infectologia Evandro Chagas, Fiocruz, Rio de Janeiro, RJ, Brazil.\', \'Department of Molecular Pharmacology and Therapeutics, Columbia University, New York, NY, 10032, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1093/jac/dkab072
?:hasPublicationType
?:journal
  • The Journal of antimicrobial chemotherapy
is ?:pmid of
?:pmid
?:pmid
  • 33880524
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • In vitro antiviral activity of the anti-HCV drugs daclatasvir and sofosbuvir against SARS-CoV-2, the aetiological agent of COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33880524>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33880524>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all